NCT02974933 - Apatinib Mesylate Combined With Pemetrexed in the Treatment of Pretreated Advanced Non-squamous Non-small Cell Lung Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

November 30, 2017

Study Completion Date

November 30, 2018

Conditions

Nonsmall Cell Lung Cancer

Interventions

DRUG

Apatinib combined with pemetrexed

For those pretreated non-squamous non-small cell lung cancer, treat with apatinib 500mg Qd, po.combined with pemetrexed continue until disease progression

Trial Locations (1)

430079

RECRUITING

Ou wuling, Wuhan